10Narita M, Tanaka H, Abe S, et al. Close association between pul monary disease manifestation in Mycoplasma pneumoniae infection and enhanced local production of interleukin 18 in the lung independent of gamma interferon [ J ]. Clin Diagn Lab Immunol,2000,7 (6) :909-914.
5Petitjean J, Vabret A, Gouarin S, et al. Evaluation of commercial immunaglobulinG(lsG) and IgM- specific enzyme immtmoassays for diagnosis of mycoplasma pneumoniae infections [ M ]. J Clin Mi- crobiol, 2002,40( 1 ) :165 - 171.
6Shimizu T,Kida Y,Kuwano K.Cytoadherence-dependent induction of inflammatory responses by Mycoplasma pneumoniae.Immunology,2011,133:51-61.
7Techasaensiri C,Tagliabue C,Cagle M,et al.Variation in colonization,ADP-ribosylating and vacuolating cytotoxin,and pulmonary disease severity among mycoplasma pneu-moniae strains.Am J Respir Crit Care Med,2010,182:797-804.
8Narita M.Pathogenesis of extrapulmonary manifestations of Mycoplasma pneumoniae infection with special reference to pneumonia.J Infect Chemother,2010,16:162-169.
9Youn YS,Lee KY,Hwang JY,et al.Differ ence of clinical features in childhood Mycoplasma pneumoniae pneumonia.BMC Pediatr,2010,10:4.
10Youn YS,Lee KY,Hwang JY,et al.Comparison of diagnostic methods and the changes of IgG subclasses in children with Mycoplasma pneumoniae pneumonia.Pediatr Allergy Respir Dis,2009,19:137-145.
